Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

ObjectiveToward the limited real-world data concerning the treatment response to brand direct-acting antiviral agents (DAAs) therapy, we proposed to evaluate the efficacy and safety of DAAs for the treatment of chronic hepatitis C virus (HCV) in mainland China.MethodsIn this retrospective, single-ce...

Full description

Bibliographic Details
Main Authors: Huan Xia, Chengzhen Lu, Yin Wang, Silvere D. Zaongo, Yue Hu, Yue Wu, Zhongfang Yan, Ping Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
direct acting antivirals
hepatitis C
real-world experience
DAAs
HCV
China
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00710/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00710/full

Similar Items